Procalcitonin use in acute exacerbations of COPD

T. Medveczky, M. Jackson (Haywards Heath, United Kingdom)

Source: Annual Congress 2011 - COPD exacerbation
Session: COPD exacerbation
Session type: Thematic Poster Session
Number: 563
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Medveczky, M. Jackson (Haywards Heath, United Kingdom). Procalcitonin use in acute exacerbations of COPD. Eur Respir J 2011; 38: Suppl. 55, 563

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Antibiotics in acute exacerbation of asthma and COPD
Source: Eur Respir Monogr 2017; 75: 150-158
Year: 2017


Management of acute COPD exacerbations
Source: Annual Congress 2013 –Recommendations from the ERS/ATS Guideline on COPD Exacerbation Prevention
Year: 2013


Rehospitalizations for an acute exacerbation among patients with COPD
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015

Acute management of COPD exacerbations
Source: Annual Congress 2012 - ERS COPD exacerbation guidelines: methodologies and overview
Year: 2012


Acute exacerbations of COPD
Source: Eur Respir Monogr 2016; 74: 48-65
Year: 2016


Prognosis after hospitalization for acute exacerbations of COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 209s
Year: 2001

Procalcitonin to guide antibiotic administration in COPD exacerbations: a meta-analysis
Source: Eur Respir Rev 2017; 26: 160073
Year: 2017



COPD patients admitted in ICU for acute exacerbation: Impact of exacerbation factors on prognosis
Source: International Congress 2016 – Dealing with the complexity of critically-ill patients
Year: 2016


Serum periostin in patients hospitalized for COPD exacerbations
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015


An evaluation of exacerbations in COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 89s
Year: 2004

The prognostic value of cardiac and inflammatory biomarkers in acute exacerbations of COPD
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016

BNP level in patients with COPD exacerbations
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013


NIV in COPD: acute exacerbation and beyond
Source: ERS course 2015
Year: 2015




Our experience of procalcitonin assay in identifying bacterial COPD exacerbations
Source: Annual Congress 2011 - COPD exacerbation
Year: 2011

Pollutant-induced acute exacerbations of asthma and COPD
Source: ERS Lung Science Conference 2019
Year: 2019


Is CRP a reliable diagnostic tool for infective exacerbations of COPD?
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013


Screening eosinophil counts and risk of exacerbations after inhaled corticosteroid withdrawal in severe COPD
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016


The role of biomarkers in predicting outcomes in acute exacerbations of chronic obstructive pulmonary disease (AECOPD)
Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU
Year: 2013


Evaluation of COPD exacerbations using the EXACT-U
Source: Annual Congress 2010 - COPD exacerbation
Year: 2010